Recent advances include enhancement of CRISPR-Cas9 gene editing precision by inducing autophagy to shift DNA repair toward homologous recombination, increasing accuracy of genome modifications. Novel open-source AI models improve small-molecule binding affinity predictions, accelerating drug design pipelines. Additional breakthroughs include comprehensive CRISPR libraries enabling multi-gene edits in crop plants and new inhibitors targeting cancer-related proteins, pushing the frontiers of therapeutic molecular engineering.